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Amyloidosis  constitutes  a  heterogeneous  group  of diseases  characterized  by  the 
deposition  of proteinaceous material  composed mainly of fibrils  having a  fl-pleated 
sheet  configuration  (1).  The  nature  of some of these  deposits  has  been  clarified  in 
recent years, and it has been shown that under appropriate conditions a  number of 
proteins can form fibrils that exhibit the histologic and physicochemical properties of 
amyloid. In the form associated with plasma cell proliferation,  the fibrillar protein is 
an  intact  immunoglobulin  light  chain  and/or  its  amino  terminal  variable-region 
fragment  (2), whereas  the deposits  in the  acquired  "secondary amyloidosis"  and  in 
familial  Mediterranean  fever  consist  of the  AA  protein,  which  is  a  degradation 
product  of an  acute  phase  reactant,  serum  AA protein  (3,  4).  The  nature  of the 
fibrillar  protein  in  certain  heredofamilial  forms  of amyloidosis  that  demonstrate 
autosomal-dominant  inheritance  is  only now being defined.  In the  case of familial 
amyloidotic  polyneuropathy  of Portuguese  origin,  it  was  shown  that  the  fibrillar 
protein  was  antigenically  related  to prealbumin  (5),  and  in  two  Swedish  relatives, 
preliminary biochemical analyses support this suggestion (6,  7). 
The purpose of this paper is to report on the purification and primary structure of 
proteins  isolated  from amyloid fibrils from a  patient  of Jewish origin suffering from 
familial amyloidotic polyneuropathy with systemic involvement. 
Materials  and Methods 
Source of Tissue Purification of Amyloid Fibrils and Subunits.  The patient  (S.K.O.), a 28-year-old 
Ashkenazi Jew, suffered from progressive neuropathy and blindness because of vitreous deposits 
of amyloid. His father had died at  the age of 29 with  an  identical disease  (B.  Fishel et  al., 
manuscript  in preparation).  Tissues were obtained  from the patient  at  an autopsy after he 
committed suicide. Extraction of amyloid fibrils was performed from the thyroid and spleen, as 
described by Pras et al.  (8). The yield from the thyroid was 2.1 g of dry fibrils  from 18 g of wet 
tissue  and from the spleen,  1.8 g of dry fibrils  from 60 g of wet tissue,  Amyloid fibrils  were 
dissolved in 6 M  guanidine HCI, pH  10.2, in the presence of 0.17  M  dithiothreitol  or 1% fl- 
mercaptoethanol and then fractionated on Sephadex G-100 columns equilibrated  with 5 M 
guanidine  HC1  in  1 M  acetic acid.  Purity of protein  fractions and  molecular weight  were 
determined  by sodium  dodecyl sulfate-polyacrylamide gel  electrophoresis  (SDS-PAGE)  (9). 
Antibodies were made in rabbits by repeated injections of purified peak IV (Fig.  1) in complete 
Freund's adjuvant. 
Amino Acid Analysis and Amino Acid Sequence.  Amino acid analysis was performed on a Durrum 
model D-500 amino acid analyzer  (Durrum  Instrument  Corp.,  Sunnyvale,  Calif.).  Samples 
were hydrolyzed in 0.2 ml 6 N  HC1 under vacuum for 24 h at  110°C. 40 #1 of a  10% aqueous 
solution  of phenol  was  added  to  prevent  degradation  of tyrosine.  Automated  amino  acid 
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FIG.  I.  Fractionation of S.K.O. amyloid fribrils from thyroid on a 2.6 X  100-cm Sephadex G-100 
column equilibrated in l M acetic acid/5 M  guanidine. Fractions (2.9 ml/tube) were collected. 
sequencing was performed on a  Beckman 890(] sequencer (Beckman Instruments, Inc., Fuller- 
ton,  Calif.).  Phenylthiohydantoin amino acids  were  identified by high pressure  liquid  chro- 
matography  (HPLC) performed on a Waters HPLC model ALC/GPC-204 (Waters  Instru- 
ments, Inc., Rochester, Minn.) prepacked with a C 18/#-Bondapak column (Waters Instruments, 
Inc.)  and  eluted  with  a  methanol  water gradient  and  by amino  acid  analysis  after back 
hydrolysis of the phenyhhiohydantoin amino acids (10). 
Results 
Fig.  1  shows  the  pattern  obtained  when  the  amyloid  from  the  thyroid  was 
fractionated on Sephadex G-100. Peak I (void volume) contained mucopolysaccharide 
material, which is found in all types of amyloid fibrils (11).  Peak II consisted of P 
component (1) as indicated by antigenic analysis and molecular weight determination 
on  SDS  gels.  Peaks  III,  IV,  and  V  contained  14,000-,  9,000-,  and  5,000-mol  wt 
proteins, respectively. Peaks III and IV were rechromatographed on a G-75 Sephadex 
column and peak V on Uhragel AC54 (LKB Instruments Inc., Rockville, Md.) in 5M 
Guan/1 M  HAC. Their purity was determined on SDS gels (Fig. 2), and their amino 
acid compositions are shown  in Table I.  Fractionation of amyloid fibrils obtained 
from spleen yielded a similar pattern to that in Fig.  1, although peaks IV and V were 
less prominent. 
The partial amino acid sequences of peaks III, IV, and V  are shown in Fig. 3 and 
compared  to  the  sequence  of serum  prealbumin  (12).  Based  on  their  amino  acid 
composition, molecular weight, and partial sequence, it would appear that peak III 
represents the intact prealbumin subunit, peak IV consists of the carboxy terminus 
starting  at  residue  49,  and  peak  V  contains  the  first  48  residues.  Although  the 
homology is striking,  the sequence shows  a  substitution of glycine for threonine at 
position  49.  The  heterogeneity  at  positions  52,  59,  and  62  (Leu,  Glu,  and  Val, 
respectively), in both thyroid and spleen, probably resulted from a  second cleavage 
between positions 51 and 52, which gave rise to a minor contaminant. 
A  sample of vitreous fluid was  obtained at surgery and was  extracted once with PRAS  ET  AL.  BRIEF  DEFINITIVE  REPORT  991 
Fro.  2.  SDS-PAGE  17% slab gel of impure amyloid fibrils extracted  from thyroid  (T) and spleen 
(S). Peaks III, IV, and V  are purified components from Fig.  1. M, markers; bovine serum albumin, 
67,000  mol wt;  ovalbumin, 45,000  mol wt;  chymotrypsinogen A,  25,000  mol  wt;  ribonuclease  A, 
13,700 tool wt; and AA protein, 8,000 mol wt. 
TABLE  1 
Amino Acid Composition* of Peaks III, IV, and V from Fig.  1, Compared 
with Human Prealbumin and with Fragments 1-48 and 49-127 
Prealbu-  Prealbu-  Prealbu- 
S.K.O. IIl  rain  S.K.O. IV  min (49-  S.K.O. V  min (1- 
127)  48) 
Cyst  0.9  (1)§  Lo  (t) 
Asp  9.2  (8)  4.8  (4)  4.4  (4) 
Thr  10.4  (12)  7.7  (9)  2.6  (3) 
Ser  11.2  (11)  7.7  (8)  3.6  (3) 
Glu  14.4  (12)  10.0  (10)  2.7  (2) 
Pro  7.4  (8)  4.5  (4)  3.8  (4) 
Gly  9.5  (10)  5.8  (5)  3.7  (5) 
Ala  12, 7  (12)  7.0  (6)  6.0  (6) 
Val  10.5  (12)  5.8  (6)  5.6  (6) 
Met  1.1  (1)  1.0  (1) 
lie  5.7  (5)  3.8  (4)  1.6  (1) 
Leu  8.7  (7)  5.3  (5)  2.5  (2) 
Tyr  5.5  (5)  4.6  (5) 
Phe  4.6  (5)  3.2  (3)  1.1  (2) 
His  3.9  (4)  2.8  (3)  1.0  (1) 
Lys  7.4  (8)  4.0  (4)  3.0  (4) 
Arg  4.0  (4)  1.9  (2)  2.0  (2) 
Trp  NDII  (2)  ND  (1)  ND  (1) 
* Mean value of four runs (not corrected). 
:~ Determined as cysteic acid. 
§ In parentheses are expected  residues based on the published amino acid sequence of the 
intact prealbumin subunit and its amino and carboxy terminal fragments (12). 
tl Not done. 
distilled water and subjected to PAGE, amino acid, and N  terminal analysis. A  single 
band with  an  ~  15,000  mol wt  was obtained with  an amino acid analysis similar to 
prealbumin. The amino terminus was glycine. 
Antiserum to peak IV (which is a  weak antiserum) reacted against peaks III and IV 
and the patient's serum.  It did not react with normal human  sera, isolated immuno- 992 
PA 
Peak III 
Peak V 
PA 
Peak IV 
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Gly  -  Pro-Thr-Gly-Thr-Gly-Glu-Ser-Lys-Cys-Pro-Leu-Met  -Val-  Lys-Val-Leu-Asp-Ala-Val 
__.(Thr)~(  )  (Cys)  (Met) 
49  60  70 
Thr-Ser-G•u-Ser-G•y-G•u-Leu•His•G•y-Leu•Thr-Thr-G•x-G•x•G•u-Phe-Val-G•u-G•y-••e-Tyr-Lys 
Gly  (  )  (Thr)Glu-Glu 
FIG. 3.  The amino terminal sequence of fragments Peaks III, IV, and V from Fig. 1 compared 
with that  of prealbumin (PA [12]). Empty parentheses, no amino acid detected; amino acid in 
parentheses, tentative. 
globulin,  prealbumin,  and  serum  AA  proteins.  On  the  other  hand,  antibodies  to 
human prealbumin reacted with peaks III and IV. 
Discussion 
The neuropathic heredofamilial amyloidoses represent a variety of syndromes that 
generally  demonstrate  autosomal-dominant  modes  of  inheritance  (13).  Although 
amyloid  deposits  can  be  detected  in  several  tissues,  such  as  liver,  spleen,  thyroid, 
gastrointestinal tract, and heart, in many of the heredofamilial types there is promi- 
nent involvement of the peripheral nerves, and they have been classified according to 
the clinical  syndrome and  to the country or ethnic  group in  which  they were first 
described. Recently, Costa et al.  (5)  presented evidence that the amyloid deposits in 
Portuguese familial amyloid polyneuropathy shared common antigenic determinants 
with human prealbumin. This appears to be true also in amyloid obtained from two 
Swedish patients (6,  7), in whom limited amino acid sequence studies supported this 
possibility.  Human  prealbumin  is  a  protein  (54,980  mol  wt)  that  possesses  a  fl- 
structure and is composed of four identical subunits.  Each subunit  has a13,745  mol 
wt and contains  127 amino acids. Prealbumin forms a  complex with retinol-binding 
protein, which is a carrier protein for vitamin A and is also involved in the transport 
of thyroxine (12). 
The  amino  acid  sequence  of amyloid  fibrils  extracted  from organs  of a  patient 
(S.K.O.)  of Jewish origin indicates that  it is also a  prealbumin-related protein. The 
S.K.O.  proteins  are particularly informative because the amyloid fibrils were com- 
posed of the intact prealbumin molecule (Fig.  1, peak III) and two fragments (peaks 
IV and V) resulting from enzymatic cleavage between positions 48 and 49 (Lys-Gly). 
Furthermore, at position 49 there appears to be an amino acid substitution  because 
Thr was found in normal human prealbumin (12)  and Gly in S.K.O. amyloid. Based 
on the x-ray diffraction studies of Blake et al.  (14)  and the tendency of Gly to act as 
a helix breaker (15), it seems possible that the molecule is more susceptible to digestion 
at  this  site.  It  is  conceivable,  therefore,  that  in  the  S.K.O.  family a  mutation  has 
occurred,  leading  to  the  production  of an  unusual  prealbumin  that  is  abnormally 
degraded, bound, and/or precipitated. 
Alternatively, prealbumin may be genetically polymorphic, and S.K.O.  may rep- 
resent an as yet undiscovered isotype or an allelic form. It is possible that additional 
variations from the prototype sequence exist.  Studies  are in  progress to answer this 
question and to detect other polymorphisms. 
Summary 
Amyloid fibrils were isolated  from spleen  and  thyroid obtained  at  autopsy from 
one patient  (S.K.O.) of Jewish origin with familial amyloidotic polyneuropathy. Gel 
titration on Sephadex G100 after solubilization  in 5 M  guanidine HC1 yielded three PRAS ET AL.  BRIEF  DEFINITIVE REPORT  993 
major components with  14,000, 9,000, and 5,000 mol wt, respectively. The two larger 
components  shared  antigenic  determinants  with  human  prealbumin.  Amino  acid 
analysis and amino terminal sequence studies revealed the  14,000-tool wt protein to 
be  an  intact  prealbumin  subunit.  The 9,000-tool wt  fragment obtained  in  highest 
yield encompassed the  region from position 49-127  and  the  5,000  mol wt  fraction 
encompassed  the  amino  terminal  of prealbumin  (position  1-48).  An  amino  acid 
substitution  (Gly/Thr)  was  detected  at  position  49,  where  enzymatic cleavage oc- 
curred. Thus, several prealbumin-derived fragments, predominantly the carboxyl end, 
constitute the amyloid fibrils in a  heredofamilial amyloidosis syndrome of dominant 
inheritance. 
Received  for publication 8June 1981. 
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